APA (7th ed.) Citation

DA, H., & M, S. (2022). The challenge of pharmacological thromboprophylaxis in ICU patients: Anti-FXa activity does not constitute the simple solution. Author's reply. Intensive care medicine, 48(8), 1118. https://doi.org/10.1007/s00134-022-06768-0

Chicago Style (17th ed.) Citation

DA, Hofmaenner, and Singer M. "The Challenge of Pharmacological Thromboprophylaxis in ICU Patients: Anti-FXa Activity Does Not Constitute the Simple Solution. Author's Reply." Intensive Care Medicine 48, no. 8 (2022): 1118. https://doi.org/10.1007/s00134-022-06768-0.

MLA (9th ed.) Citation

DA, Hofmaenner, and Singer M. "The Challenge of Pharmacological Thromboprophylaxis in ICU Patients: Anti-FXa Activity Does Not Constitute the Simple Solution. Author's Reply." Intensive Care Medicine, vol. 48, no. 8, 2022, p. 1118, https://doi.org/10.1007/s00134-022-06768-0.